The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
GENOCEA BIOSCIENCES INC | COM | 372427104 | 3,016 | 3,525,000 | SH | SOLE | 3,525,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 7,581 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 4,163 | 1,411,247 | SH | SOLE | 1,411,247 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 29,588 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 6,228 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 773 | 750,792 | SH | SOLE | 750,792 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 9,520 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 22,768 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 8,085 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 10,716 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 3,750 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,169 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
ENDOCYTE INC | COM | 29269A102 | 6,900 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 24,650 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 2,759 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 8,608 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
GLYCOMIMETICS INC | COM | 38000Q102 | 6,452 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 6,056 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 4,608 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 4,143 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 6,871 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 7,620 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
LANNET INC | COM | 516012101 | 3,400 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 9,214 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 4,186 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 20,683 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 10,938 | 242,000 | SH | SOLE | 242,000 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 6,569 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,070 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 11,641 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 12,429 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 23,132 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 4,776 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 16,480 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
ZAFGEN INC | COM | 98885E103 | 1,046 | 102,263 | SH | SOLE | 102,263 | 0 | 0 | ||
MOTUS GI HLDGS INC | COM | 62014P108 | 719 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 5,562 | 186,019 | SH | SOLE | 186,019 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 684 | 52,000 | SH | SOLE | 52,000 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 947 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
SPECTRUM PHARMACEUTICALS INC | COM | 84763A108 | 608 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 1,115 | 15,700 | SH | SOLE | 15,700 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 6,573 | 23,500 | SH | SOLE | 23,500 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 828 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 525 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 122 | 2,000 | SH | Call | SOLE | 2,000 | 0 | 0 | |
LANNET INC | COM | 516012101 | 520 | 2,000 | SH | Call | SOLE | 2,000 | 0 | 0 |